Aerospace startup Boom says they've proven quiet supersonic flight is possible with their passenger airplanes after a ...

Strength in the pharmaceutical major’s oncology business offset weak China sales, but the company has warned of a potential ...

AstraZeneca on Thursday said it could face a fine of up to $4.5 million in China over suspected unpaid import taxes, raising ...

Strong results from AstraZeneca helped London's blue-chip index notch a record close on Thursday, while a dovish majority ...

Lord Storey says he fears Merseyside was "not a high priority" on the government's growth agenda.

Morgan Stanley analyst Sarita Kapila initiated coverage of AstraZeneca (AZN) with an Overweight rating and 14,500 GBp price target The firm ...

The FDA on Tuesday signed off on SpringWorks Therapeutics’ mirdametinib—now to carry the brand name Gomekli—for the treatment ...

We recently published a list of 10 Safest Dividend Stocks in the UK. In this article, we are going to take a look at where ...

Today, Benzinga's options scanner spotted 9 options trades for AstraZeneca. This isn't normal. The overall sentiment of these ...

Shares of AstraZeneca Pharma India Ltd closed at ₹7,450 on the BSE, down 1.29% ahead of the earnings announcement.

Indicates growing incidence of cancer among Indian population; five out of top 20 new brand launches are cancer drugs ...

Astrazeneca Pharma India advanced 1.21% to Rs 7557.05 after the company's standalone net profit surged to Rs 54.68 crore in Q3 FY25 as compared with Rs 15.80 crore in Q3 FY24.